Virtual Issue: Antibody-mediated rejection (ABMR)
Published on 02/17/10Guest Editors: Drs. Philip F. Halloran and Michael Mengel
Read this Virtual Issue on Antibody-mediated rejection (ABMR)
Antibody-mediated rejection (ABMR) is increasingly recognized as one of the biggest challenges in organ transplantation. This virtual issue presents a sample of articles addressing ABMR issues selected from many other articles of interest in AJT on the basis of citation rates and download rates, reflecting impact on the transplantation community. With the exception of liver, ABMR phenotypes probably contribute to late loss of many organ transplants and islet transplants. ABMR can be subtle or explosive, and presents in two main variants: early onset in presensitized persons, often with positive crossmatches; and late insidious onset, usually with de novo anti HLA, particularly anti class II.
Virtual Issue compiled online 17 Feb 2010
Journal Menu
Special Features
For Authors
- Manuscript Submissions - Operating Procedure Instruction to Authors
- Supplement Guide
- Submit Your Manuscript
For Readers
Get Access
Sales & Services



